<p>Frontier Capital Management Co. LLC 在最近向證券交易委員會的披露中表示，在第二季度減少了對 Align Technology, Inc. (NASDAQ:ALGN - 免費報告) 的持股比例，降幅為 7.5%。該基金在季度內出售了 18,201 股後，持有該醫療設備提供商的股票 224,025 股。根據其最近向證券交易委員會的備案，Frontier Capital Management Co. LLC 約持有 Align Technology 0.31% 的股份，價值 42,415,000 美元。</p>
<p>獲取 <strong>Align Technology</strong> 警報：</p>
<ul>
<li>為什麼這三隻科技股可能是你忽視的最佳機會</li>
</ul>
<p>其他大型投資者最近也增加或減少了對該公司的持股。Invesco Ltd. 在第一季度將其在 Align Technology 的股份增加了 12.7%。Invesco Ltd. 目前持有該醫療設備提供商的 1,219,715 股股票，價值 193,764,000 美元，此前在上個季度又收購了 137,553 股。Federated Hermes Inc. 在第二季度將其在 Align Technology 的持股增加了 31.0%。Federated Hermes Inc. 目前持有 926,733 股該醫療設備提供商的股票，價值 175,458,000 美元，此前在上個季度又收購了 219,219 股。瑞士銀行資產管理公司（UBS AM）在第一季度將其在 Align Technology 的股份增加了 32.2%。瑞士銀行資產管理公司目前持有 832,313 股該醫療設備提供商的股票，價值 132,221,000 美元，此前在上個季度又購買了 202,616 股。挪威銀行在第二季度收購了 Align Technology 的新頭寸，價值約 155,297,000 美元。最後，Navera Investment Management Ltd. 在第二季度將其在 Align Technology 的持股增加了 3.0%。Navera Investment Management Ltd. 目前持有 787,559 股該醫療設備提供商的股票，價值 149,126,000 美元，此前在上個季度又收購了 23,080 股。目前，88.43% 的股票由機構投資者和對沖基金持有。</p>
<h2>Align Technology 股價上漲 3.5%</h2>
<p>Align Technology 股票週四開盤價為 164.58 美元。該股票的 50 日移動平均價格為 139.04 美元，200 日移動平均價格為 155.04 美元。該公司的市值為 118.1 億美元，市盈率為 31.90，市盈率/增長比率為 1.93，貝塔值為 1.86。Align Technology, Inc. 的一年低點為 122.00 美元，一年高點為 246.19 美元。</p>
<ul>
<li>買入抄底？這些盈利失誤提供長期上漲潛力</li>
</ul>
<p>Align Technology (NASDAQ:ALGN - 獲取免費報告) 最近在 10 月 29 日（星期三）發佈了其財報。該醫療設備提供商報告本季度每股收益 (EPS) 為 2.61 美元，超出分析師一致預期的 2.38 美元，超出幅度為 0.23 美元。Align Technology 的淨利潤率為 9.50%，股本回報率為 13.96%。該公司本季度的收入為 9.9569 億美元，而分析師預期為 9.8075 億美元。去年同期，該公司的每股收益為 2.35 美元。該公司的季度收入同比增長 1.8%。平均而言，股票分析師預測 Align Technology, Inc. 本財年的每股收益將達到 7.98 美元。</p>
<h2>分析師設定新目標價</h2>
<p>ALGN 最近成為多份分析師報告的主題。摩根士丹利在 10 月 30 日的研究報告中將 Align Technology 的目標價從 142.00 美元上調至 154.00 美元，並給予該公司 “持平” 評級。瑞士銀行集團在 10 月 16 日的研究報告中將 Align Technology 的目標價從 160.00 美元下調至 155.00 美元，並對該公司設定了 “中性” 評級。Weiss Ratings 在 10 月 8 日的報告中將 Align Technology 的評級從 “持有 (c-)” 下調至 “賣出 (d+)”。華爾街 Zen 在 11 月 8 日的研究報告中將 Align Technology 的評級從 “持有” 上調至 “買入”。最後，Leerink Partners 在 10 月 30 日的研究報告中將 Align Technology 的目標價從 172.00 美元上調至 189.00 美元。一位研究分析師對該股票給予了強烈買入評級，六位分析師給予了買入評級，八位分析師給予了持有評級，兩位分析師給予了賣出評級。根據 MarketBeat，Align Technology 目前的共識評級為 “持有”，平均目標價為 175.00 美元。</p>
<ul>
<li>MarketBeat 週迴顧：12/25 - 12/29</li>
</ul>
<p><strong>查看我們對 Align Technology 的最新股票分析</strong></p>
<h2>Align Technology 公司簡介</h2>
<p>（免費報告）</p>
<p>Align Technology, Inc. 設計、製造和銷售 Invisalign 隱形矯正器，以及 iTero 口內掃描儀和服務，面向美國、瑞士及國際的正畸醫生和普通牙醫。該公司的隱形矯正器業務提供全面的產品，包括滿足年輕患者正畸需求的 Invisalign 綜合套餐，如下頜前移、合規指示器和牙齒萌出補償；以及針對一般年齡在六到十歲之間的年輕患者的 Invisalign 第一階段 I 和 Invisalign 第一綜合階段 II 套餐，這是一種初生牙和恆牙的混合。</p>
<h2>另見</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Align Technology</li>
<li>交易股票：相對強弱指數及其用途</li>
<li>GameStop 看起來破碎：為什麼 GME 可能在 2026 年崩潰</li>
<li>如何投資藍籌股</li>
<li>市場動量：三隻有望大幅突破的股票</li>
<li>消費品股票，解析</li>
<li>Casey’s General Stores 將繼續上漲的三大理由</li>
</ul>
<p><strong>想看看其他對沖基金持有的 ALGN 嗎？</strong> 訪問 HoldingsChannel.com 獲取 Align Technology, Inc. (NASDAQ:ALGN - 免費報告) 的最新 13F 備案和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在愛齊科技嗎？</h2>
<p>在考慮愛齊科技之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而愛齊科技並不在名單上。</p>
<p>雖然愛齊科技目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

愛齊科技

<p>Frontier Capital Management Co. LLC 在第二季度減少了對愛齊科技的持股 7.5%。愛齊科技的股票開盤價為 164.58 美元，市值為 118.1 億美元。分析師的評級意見不一，普遍持有的共識評級，平均目標價為 175.00 美元。該公司報告第三季度每股收益為 2.61 美元，超出預期，營收同比增長 1.8%</p>

<p>Frontier Capital Management Co. LLC reduced its holdings in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 7.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 224,025 shares of the medical equipment provider's stock after selling 18,201 shares during the quarter. Frontier Capital Management Co. LLC owned approximately 0.31% of Align Technology worth $42,415,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>Frontier Capital Management Co. LLC 在最近向證券交易委員會的披露中表示，在第二季度減少了對 Align Technology, Inc. (NASDAQ:ALGN - 免費報告) 的持股比例，降幅為 7.5%。該基金在季度內出售了 18,201 股後，持有該醫療設備提供商的股票 224,025 股。根據其最近向證券交易委員會的備案，Frontier Capital Management Co. LLC 約持有 Align Technology 0.31% 的股份，價值 42,415,000 美元。</p>
</div><p>Get <strong>Align Technology</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Align Technology</strong> 警報：</p>
</div><ul>
<li>Why These 3 Tech Stocks Could Be the Best Opportunities You're Overlooking</li>
</ul>
<div class="lb-trans"><ul>
<li>為什麼這三隻科技股可能是你忽視的最佳機會</li>
</ul>
</div><p>Other large investors have also recently added to or reduced their stakes in the company. Invesco Ltd. grew its stake in shares of Align Technology by 12.7% during the first quarter. Invesco Ltd. now owns 1,219,715 shares of the medical equipment provider's stock valued at $193,764,000 after acquiring an additional 137,553 shares in the last quarter. Federated Hermes Inc. grew its holdings in Align Technology by 31.0% during the 2nd quarter. Federated Hermes Inc. now owns 926,733 shares of the medical equipment provider's stock worth $175,458,000 after acquiring an additional 219,219 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Align Technology by 32.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 832,313 shares of the medical equipment provider's stock valued at $132,221,000 after purchasing an additional 202,616 shares in the last quarter. Norges Bank acquired a new position in Align Technology in the second quarter worth about $155,297,000. Finally, Navera Investment Management Ltd. increased its holdings in shares of Align Technology by 3.0% in the 2nd quarter. Navera Investment Management Ltd. now owns 787,559 shares of the medical equipment provider's stock valued at $149,126,000 after acquiring an additional 23,080 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他大型投資者最近也增加或減少了對該公司的持股。Invesco Ltd. 在第一季度將其在 Align Technology 的股份增加了 12.7%。Invesco Ltd. 目前持有該醫療設備提供商的 1,219,715 股股票，價值 193,764,000 美元，此前在上個季度又收購了 137,553 股。Federated Hermes Inc. 在第二季度將其在 Align Technology 的持股增加了 31.0%。Federated Hermes Inc. 目前持有 926,733 股該醫療設備提供商的股票，價值 175,458,000 美元，此前在上個季度又收購了 219,219 股。瑞士銀行資產管理公司（UBS AM）在第一季度將其在 Align Technology 的股份增加了 32.2%。瑞士銀行資產管理公司目前持有 832,313 股該醫療設備提供商的股票，價值 132,221,000 美元，此前在上個季度又購買了 202,616 股。挪威銀行在第二季度收購了 Align Technology 的新頭寸，價值約 155,297,000 美元。最後，Navera Investment Management Ltd. 在第二季度將其在 Align Technology 的持股增加了 3.0%。Navera Investment Management Ltd. 目前持有 787,559 股該醫療設備提供商的股票，價值 149,126,000 美元，此前在上個季度又收購了 23,080 股。目前，88.43% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Align Technology Trading Up 3.5%</h2>
<div class="lb-trans"><h2>Align Technology 股價上漲 3.5%</h2>
</div><p>Shares of Align Technology stock opened at $164.58 on Thursday. The stock has a 50-day moving average price of $139.04 and a 200 day moving average price of $155.04. The company has a market cap of $11.81 billion, a P/E ratio of 31.90, a P/E/G ratio of 1.93 and a beta of 1.86. Align Technology, Inc. has a 1 year low of $122.00 and a 1 year high of $246.19.</p>
<div class="lb-trans"><p>Align Technology 股票週四開盤價為 164.58 美元。該股票的 50 日移動平均價格為 139.04 美元，200 日移動平均價格為 155.04 美元。該公司的市值為 118.1 億美元，市盈率為 31.90，市盈率/增長比率為 1.93，貝塔值為 1.86。Align Technology, Inc. 的一年低點為 122.00 美元，一年高點為 246.19 美元。</p>
</div><ul>
<li>Buy the Dip? These Earnings Misses Offer Long-Term Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>買入抄底？這些盈利失誤提供長期上漲潛力</li>
</ul>
</div><p>Align Technology (NASDAQ:ALGN - Get Free Report) last issued its earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.38 by $0.23. Align Technology had a net margin of 9.50% and a return on equity of 13.96%. The company had revenue of $995.69 million during the quarter, compared to analyst estimates of $980.75 million. During the same quarter last year, the business posted $2.35 EPS. The company's revenue for the quarter was up 1.8% on a year-over-year basis. On average, equities analysts forecast that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Align Technology (NASDAQ:ALGN - 獲取免費報告) 最近在 10 月 29 日（星期三）發佈了其財報。該醫療設備提供商報告本季度每股收益 (EPS) 為 2.61 美元，超出分析師一致預期的 2.38 美元，超出幅度為 0.23 美元。Align Technology 的淨利潤率為 9.50%，股本回報率為 13.96%。該公司本季度的收入為 9.9569 億美元，而分析師預期為 9.8075 億美元。去年同期，該公司的每股收益為 2.35 美元。該公司的季度收入同比增長 1.8%。平均而言，股票分析師預測 Align Technology, Inc. 本財年的每股收益將達到 7.98 美元。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>ALGN has been the subject of a number of analyst reports. Morgan Stanley boosted their price objective on Align Technology from $142.00 to $154.00 and gave the company an &#34;equal weight&#34; rating in a research report on Thursday, October 30th. UBS Group decreased their target price on shares of Align Technology from $160.00 to $155.00 and set a &#34;neutral&#34; rating for the company in a research report on Thursday, October 16th. Weiss Ratings cut Align Technology from a &#34;hold (c-)&#34; rating to a &#34;sell (d+)&#34; rating in a report on Wednesday, October 8th. Wall Street Zen upgraded Align Technology from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, November 8th. Finally, Leerink Partners boosted their price target on Align Technology from $172.00 to $189.00 in a research report on Thursday, October 30th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat, Align Technology currently has a consensus rating of &#34;Hold&#34; and an average price target of $175.00.</p>
<div class="lb-trans"><p>ALGN 最近成為多份分析師報告的主題。摩根士丹利在 10 月 30 日的研究報告中將 Align Technology 的目標價從 142.00 美元上調至 154.00 美元，並給予該公司 “持平” 評級。瑞士銀行集團在 10 月 16 日的研究報告中將 Align Technology 的目標價從 160.00 美元下調至 155.00 美元，並對該公司設定了 “中性” 評級。Weiss Ratings 在 10 月 8 日的報告中將 Align Technology 的評級從 “持有 (c-)” 下調至 “賣出 (d+)”。華爾街 Zen 在 11 月 8 日的研究報告中將 Align Technology 的評級從 “持有” 上調至 “買入”。最後，Leerink Partners 在 10 月 30 日的研究報告中將 Align Technology 的目標價從 172.00 美元上調至 189.00 美元。一位研究分析師對該股票給予了強烈買入評級，六位分析師給予了買入評級，八位分析師給予了持有評級，兩位分析師給予了賣出評級。根據 MarketBeat，Align Technology 目前的共識評級為 “持有”，平均目標價為 175.00 美元。</p>
</div><ul>
<li>MarketBeat Week in Review: 12/25 - 12/29</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧：12/25 - 12/29</li>
</ul>
</div><p><strong>View Our Latest Stock Analysis on Align Technology</strong></p>
<div class="lb-trans"><p><strong>查看我們對 Align Technology 的最新股票分析</strong></p>
</div><h2>Align Technology Company Profile</h2>
<div class="lb-trans"><h2>Align Technology 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.</p>
<div class="lb-trans"><p>Align Technology, Inc. 設計、製造和銷售 Invisalign 隱形矯正器，以及 iTero 口內掃描儀和服務，面向美國、瑞士及國際的正畸醫生和普通牙醫。該公司的隱形矯正器業務提供全面的產品，包括滿足年輕患者正畸需求的 Invisalign 綜合套餐，如下頜前移、合規指示器和牙齒萌出補償；以及針對一般年齡在六到十歲之間的年輕患者的 Invisalign 第一階段 I 和 Invisalign 第一綜合階段 II 套餐，這是一種初生牙和恆牙的混合。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Align Technology</li>
<li>Trading Stocks: RSI and Why it's Useful</li>
<li>GameStop Looks Broken: Here’s Why GME Could Crash in 2026</li>
<li>How to Invest in Blue Chip Stocks</li>
<li>Market Momentum: 3 Stocks Poised for Major Breakouts</li>
<li>Consumer Staples Stocks, Explained</li>
<li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Align Technology</li>
<li>交易股票：相對強弱指數及其用途</li>
<li>GameStop 看起來破碎：為什麼 GME 可能在 2026 年崩潰</li>
<li>如何投資藍籌股</li>
<li>市場動量：三隻有望大幅突破的股票</li>
<li>消費品股票，解析</li>
<li>Casey’s General Stores 將繼續上漲的三大理由</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ALGN?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對沖基金持有的 ALGN 嗎？</strong> 訪問 HoldingsChannel.com 獲取 Align Technology, Inc. (NASDAQ:ALGN - 免費報告) 的最新 13F 備案和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ALGN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Align Technology Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在愛齊科技嗎？</h2>
</div><p>Before you consider Align Technology, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮愛齊科技之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而愛齊科技並不在名單上。</p>
</div><p>While Align Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然愛齊科技目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Align Technology, Inc. $ALGN 的股票被 Frontier Capital Management Co. LLC 出售